Carcinoma of pancreatic body and tail: Are there improvements in diagnosis and treatment modalities over the past decade?

Massimo Falconi, W. Mantovani, R. Bettini, G. Talamini, C. Bassi, S. Cascinu, C. Oliani, P. Pederzoli

Research output: Contribution to journalArticle

Abstract

Background and aim of study. The aim of the present study is to assess whether or not there has been improvement in the therapeutic strategy for body-tail pancreatic carcinoma over the past decade. Patients and methods. A total of 215 patients suffering from cytologically and histologically documented ductal carcinoma in the pancreatic body-tail, observed from 1990 to 1999, were analysed. Changes in tumour stage at diagnosis, in the percentage of patients treated surgically, in resectability rates and in the use of anticancer therapies over the years were sought. Survival curves were evaluated in relation to the treatments adopted. Results. Over the 10-year period, no significant differences were observed with respect to the stage at diagnosis, resectability or type of surgery adopted. There was a significant increase in the percentage of unoperated patients ( p

Original languageEnglish
Pages (from-to)421-427
Number of pages7
JournalDigestive and Liver Disease
Volume35
Issue number6
DOIs
Publication statusPublished - Jun 2003

    Fingerprint

Keywords

  • 5-FU
  • Chemotherapy
  • Gemcitabine
  • Pancreatic cancer

ASJC Scopus subject areas

  • Gastroenterology

Cite this